Advancing your global companion diagnostics program: Insights from a recent symposium

Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Choosing the right partner-with expertise in antibody and tissue selection, cutoff design and regulatory approvals-is key to advancing global CDx programs.